Medtronic
Medtronic Boston Scientific Corp. (NYSE:BSX) and Medtronic Inc. (NYSE:MDT), locked in a seemingly eternal blood feud over market share in the cardiovascular market, now have another competition: The hunt for a new CEO.BSX chief Ray Elliott announced yesterday that he will step down at the end of the calendar year, less than two-and-a-half years after taking the position. The 61-year-old turnaround artist’s decision leaves more than seven months for what is sure to be a thorough search for a replacement — and lots of scuttlebutt flying around among industry insiders.
No comments:
Post a Comment